Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
alan, allergic, alter, andFRANK, appointsGEORGE, asthma, AstraZeneca, ASU, attached, attorney, autoimmune, bevacizumab, billion, biomarker, bladder, blockade, Boehringer, BUCHER, Calistoga, capecitabine, carl, cediranib, central, cessation, Chapter, cisplatin, cliff, Cohen, compensatory, condensed, configured, convene, cutting, degranulation, denominated, department, derecognized, discretionary, double, dual, duly, Dysregulation, edema, EFGR, endometrial, esophageal, Esq, etoposide, Evasion, feldbaum, fewer, Fran, Frank, French, gall, garber, gastroesophageal, george, Gisela, GLP, glucose, GPCR, guaranteed, hedge, Heller, hematopoietic, hereof, hereto, highest, Housing, idle, immune, inapplicable, inflammation, Ingelheim, Ingleheim, inoperable, insight, insulin, intestine, invite, irrespective, isoform, jack, karbe, Lance, language, lawfully, leasehold, led, LXRb, lymphoma, Marchesi, mast, McCormick, meaningful, mediator, member, Michael, Mitigation, Morrissey, negotiate, omitted, open, overhead, package, page, Pamela, pan, passive, peripheral, Pfizer, plasma, preceding, properly, proportion, quantify, ratification, reconsideration, recurrent, refinancing, reform, refuse, regimen, remeasured, remeasurement, repeat, Republic, resubstitution, rheumatoid, robust, RSU, Rule, salary, saving, Schwab, Semafore, Senate, signature, Simonton, statute, stead, sublease, subleased, substitute, substitution, superfamily, Taxation, thereto, thereunto, therewith, thing, Topic, trafficking, trastuzumab, Treaty, true, unaffected, undersigned, upside, User, vacate, vacated, vandetanib, VEGF, VEGFR, Vincent, virtue, Willsey, wind, withheld, withholding, wyszomierski, yearly
Removed:
aberrant, abnormal, abnormally, acceleration, adult, agricultural, anticancer, applied, approximate, arrest, attractive, attribute, balanced, Bayer, becatecarin, BioPharma, body, Bulletin, classification, compare, compelling, concerted, Consultant, contracting, conventional, convergence, creating, CropScience, damaged, deprivation, discontinue, disparate, divide, effected, EITF, enabling, encounter, endothelial, enhanced, escape, evidenced, expanding, expression, farm, feature, FIN, foregoing, Frameworkissued, FSP, fuel, fulfill, Greenhouse, guiding, Helsinn, hepatocyte, homolog, iii, improve, inappropriate, inducible, infrastructure, inhibit, inInternal, interpretation, invade, irrevocable, KDR, killing, library, mammalian, methodology, migration, modality, mutation, mutationally, nearby, oxygen, PDGFR, PDL, polycythemia, preclude, predecessor, prematurely, prescribing, programmed, promissory, rapamycin, repurchase, repurchasing, responding, revised, send, showing, simultaneously, size, specificity, spectrum, spread, SSKI, stand, STAT, step, stimulate, strain, strategically, structured, structuring, supplied, suppressor, survive, tensin, threshold, tightly, transcription, transduction, transition, transmit, travel, uncertainty, understand, unexercised, unmet, Utilizing, vera, voluntary, Woodburn
Filing tables
Filing exhibits
- 10-K Annual report
- 3.1 Amended and Restated Certificate of Incorporation
- 3.2 Certificate of Amendment of Amended and Restated Certificate of Incorporation
- 10.6 Form of Restricted Stock Unit Agreement Under the 2000 Equity Incentive Plan
- 10.10 2010 Inducement Award Plan
- 10.11 Form of Stock Option Agreement Under the 2010 Inducement Award Plan
- 10.12 Form of Restricted Stock Unit Agreement Under the 2010 Inducement Award Plan
- 10.13 Exelixis, Inc. 401(K) Plan
- 10.14 Exelixis, Inc. 401(K) Plan Adoption Agreement
- 10.20 Offer Letter Agreement
- 10.21 Compensation Information for the Company's Named Executive Officers
- 10.30 First Amendment to the Loan and Security Agreement
- 21.1 Subsidiaries of Exelixis, Inc,
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification Required by Rule 13A-14(A) or Rule 15D-14(A)
- 31.2 Certification Required by Rule 13A-14(A) or Rule 15D-14(A)
- 32.1 Certification by the Chief Executive Officer and the Chief Financial Officer
Related press release
EXEL similar filings
Filing view
External links